Benutzer: Gast  Login
Titel:

Posaconazole liquid vs tablet formulation in lung transplant recipients.

Dokumenttyp:
Journal Article; Article
Autor(en):
Stelzer, D; Weber, A; Ihle, F; Matthes, S; Ceelen, F; Zimmermann, G; Kneidinger, N; Schramm, R; Winter, H; Zoller, M; Vogeser, M; Behr, J; Neurohr, C
Abstract:
Posaconazole is an extended-spectrum triazole antifungal used in the treatment and prophylaxis of Aspergillus infections. It is available as oral suspension (POS-Liq) and delayed-release tablets (POS-Tab). The aim of this longitudinal, retrospective study was to compare the clinical effectiveness, toxicity and pharmacokinetics of POS-Liq vs POS-Tab in lung transplant recipients (LTx-recipients), who were treated with both formulations subsequently. Twenty-four consecutive LTx-recipients with 191...     »
Zeitschriftentitel:
Mycoses
Jahr:
2018
Band / Volume:
61
Heft / Issue:
3
Seitenangaben Beitrag:
186-194
Volltext / DOI:
doi:10.1111/myc.12724
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/29110351
Print-ISSN:
0933-7407
TUM Einrichtung:
I. Medizinische Klinik und Poliklinik (Kardiologie)
 BibTeX